Curzion Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Curzion Pharmaceuticals Ownership

Who owns Curzion Pharmaceuticals?

Curzion Pharmaceuticals is owned by Horizon Therapeutics Public Limited Company. It was acquired on April 2, 2020.

Curzion Pharmaceuticals Business Overview

Where is Curzion Pharmaceuticals headquartered?

Curzion Pharmaceuticals is headquartered in San Diego, California.

What sector is Curzion Pharmaceuticals in?

Curzion Pharmaceuticals is a life science company.

When was Curzion Pharmaceuticals founded?

Curzion Pharmaceuticals was founded in 2019.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 291 acquisitions of life science companies in 2020, including 24 acquisitions by private equity firms, and 267 by strategics.

Curzion Pharmaceuticals, Inc.

12230 El Camino Real, Suite 230,
San Diego, California 92130
United States,

Curzion Pharmaceuticals, Inc. is a development-stage biopharma company, and its development-stage oral selective lysophosphatidic acid 1 receptor (LPAR1) antagonist, CZN001 (renamed HZN-825). Curzion Pharmaceuticals was founded in 2019 and is based in San Diego, California.


 Subscribe to unlock this and 209,497
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.